Heart disease is the leading cause of death in the United States
According to hopkinsmedicine.org, cardiovascular disease is America’s leading health problem.
Statistics show…
- Approximately 84 million people in this country suffer from some form of cardiovascular disease, causing about 2,200 deaths a day, averaging one death every 40 seconds.
- Almost one out of every three deaths results from cardiovascular disease.
- The direct and indirect costs of cardiovascular disease and stroke are about $315 billion. This figure is increasing every year.
- An estimated 15 million U.S. adults have coronary heart disease.
- Heart failure affects well over 5 million U.S. adults.
- Cardiovascular disease is the cause of more deaths than cancer, chronic lower respiratory diseases, and accidents combined.
- About one-third of cardiovascular disease deaths occurred before age 75.
- On average, someone in the U.S. suffers a stroke every 40 seconds.
- Stroke is a leading cause of serious, long-term disability that accounts for more than half of all patients hospitalized for a neurological disease.
So what if you are on cardio medications but your body doesn’t metabolize them? With pharmacogenetic testing, you can know which medications your body can metabolize, which ones you might need a dosage change, or if you are having any drug-on-drug interactions which might prevent your medication from providing you therapy.
Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects.
And when it comes to pharmacogenetics and cardiovascular , PGx Medical leads the industry. The PGx Medical cardio panel has over 80 drugs across 4 different sections of Cardio medications. Compared to other labs who only report on 11 cardio drugs.
According to the NCBI, Cardiovascular disease (CVD) in older Americans imposes a huge burden in terms of mortality, morbidity, disability, functional decline, and healthcare costs. In light of the projected growth of the population of older adults over the next several decades, the societal burden attributable to CVD will continue to rise.
Knowing which cardio medications will metabolize in a patient and then dosing them appropriately, can help speed recovery time and save lives.
By being proactive and performing a pharmacogenetic test on your patient that includes a broad cardio panel, it will help guide you in dosing and allows you to see “inside” that patient. Pharmacogenetics gives you information you wouldn’t otherwise know and stops the trial and error process which some patients can’t afford.
For more information on pharmacogenetic testing, contact:
PGx Medical
Individualized Care – Personalized Medicine
info@pgxmed.com
405-509-5112
www.pgxmed.com